RETA by PeptiSoles (Retatrutide 30mg)

RETA by PeptiSoles (Retatrutide 30mg) is a precision-engineered peptide synthesized to explore advanced metabolic signaling through triple-receptor activation. RETA is a pioneering research compound that targets the GLP-1, GIP, and Glucagon receptors simultaneously—allowing researchers to investigate the multifaceted regulation of appetite, thermal energy expenditure, and systemic glucose homeostasis in a single study model.

Key Research Objectives

✅ Triple-Agonist Pathway Activation RETA is designed to stimulate GLP-1, GIP, and Glucagon receptors, providing a unique "triple-action" framework for studying the complex interplay of appetite control and energy regulation.

✅ Satiety Signal Modulation Investigates the potential for significantly reduced cravings and enhanced caloric intake regulation by targeting the primary satiety centers within the central nervous system.

✅ Metabolic Thermogenesis Analysis Facilitates research into the upregulation of metabolic function and adipose tissue oxidation—potentially increasing energy expenditure at rest—driven by specific glucagon pathway activation.

✅ Glycemic Response Stability Provides a medium for studying improved insulin sensitivity and the stabilization of energy levels, researching how triple-pathway activation prevents metabolic "crashes" during research protocols.

Product Specifications

1. Product Name: RETA by PeptiSoles

2. Compound: Retatrutide (Lyophilized Powder)

3. Strength: 30mg

4. Purity: 99.74% (Verified via HPLC/MS)

⚠️ Disclaimer: For laboratory research and in-vitro use only. Not for human or animal consumption.